Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

Stroke Factors May Lead to Cognitive Problems

November 9, 2011 11:08 am | News | Comments

High blood pressure and other known risk factors for stroke increase the risk of developing cognitive problems, a study funded by the National Institutes of Health has found.

TOPICS:

Scientist Awarded Grant to Study Parkinson Disease

November 9, 2011 11:05 am | News | Comments

The Scripps Research Institute has been awarded a $500,000 grant by the Michael J. Fox Foundation to study a pair of genetic mutations that could lead to a potential therapeutic target for Parkinson’s disease.

TOPICS:

MRI for Developing Brain Reports Undetectable Injuries

November 9, 2011 11:00 am | News | Comments

Pediatric neuroscientists at Oregon Health Science University Doernbecher Children’s Hospital used a high magnetic field strength MRI to reveal tiny white matter injuries in the developing brain previously undetectable using standard MRI.

TOPICS:
Advertisement

Mouse Model Developed to Study Alzheimer’s

November 9, 2011 10:56 am | News | Comments

In research at the University of Georgia, a cellular biologist and his colleagues have found that Hirano bodies may play a protective role in the progression of neurodegenerative diseases such as Alzheimer's.

TOPICS:

Alzheimer Disease Center Receives Dementia Funding

November 9, 2011 10:39 am | News | Comments

The National Institutes of Health has renewed funding to the Indiana Alzheimer Disease Center at Indiana University School of Medicine for the fifth consecutive five-year term, awarding the center a grant of $9.1 million.

TOPICS:

Culture Protocols

November 9, 2011 7:08 am | Product Releases | Comments

3D Biomatrix has developed protocols to precisely calibrate the Beckman Coulter Biomek FX laboratory automation workstation software for use with Perfecta3D hanging drop plates.

TOPICS:

Plasmid Screening

November 9, 2011 6:54 am | Product Releases | Comments

G­Biosciences' Toothpick systems allow for the rapid screening of bacterial colonies by restriction enzyme digestion analysis or polymerase chain reaction, with the Plasmid Screening Toothpick and Toothpick­PCR, respectively.

TOPICS:

Battelle Working with Molecular Imaging

November 9, 2011 6:42 am | News | Comments

Battelle has enhanced its drug discovery and development services through a collaboration with Molecular Imaging Inc., a specialty provider of small-scale nonclinical in vivo multi-modality imaging services.

TOPICS:
Advertisement

Warner Chilcott Buying Back $250M in Stock

November 9, 2011 6:37 am | News | Comments

Irish drugmaker Warner Chilcott PLC said its board has authorized the redemption of up to $250 million in stock. The buybacks will be made through the open market or privately negotiated purchases with cash generated from operations.

TOPICS:

Positive Data from Drug Dependence Study

November 9, 2011 6:30 am | News | Comments

Alkermes plc presented positive results from a long-term study of Vivitrol that showed sustained efficacy, as measured by the number of opioid-free urine screens, in patients who received Vivitrol.

TOPICS:

FDA Sets MoxDuo Review Date

November 9, 2011 6:23 am | News | Comments

QRxPharma Limited has received written acceptance from the United States Food and Drug Administration for review of the MoxDuo IR New Drug Application filed earlier this year.

TOPICS:

Newcomers Threatening Long-term Incivek Sales

November 9, 2011 6:19 am | News | Comments

Shares of Vertex Pharmaceuticals Inc. continued to slide on concerns that its hepatitis C drug Incivek, which was approved earlier this year, will be overtaken by newer drugs.

TOPICS:

Isis Losses Almost $27M for Quarter

November 9, 2011 6:16 am | News | Comments

RNA drug developer Isis Pharmaceuticals Inc. reported a larger third-quarter loss. Isis said it lost $26.9 million, or 27 cents per share, over the three months ended Sept. 30.

TOPICS:

Salix Buying Oceana for $300M

November 9, 2011 6:09 am | News | Comments

Salix Pharmaceuticals Ltd. said it turned a profit in the third quarter on rising sales of its drug Xifaxan, used to treat diarrhea and certain neurological problems. Salix also agreed to buy privately held Oceana Therapeutics for $300 million in cash.

TOPICS:

No Difference in Baraclude Versus Baraclude Plus Tenofovir

November 8, 2011 11:30 am | News | Comments

Bristol-Myers Squibb announced results from the Be?Low study, a Phase 3b clinical trial comparing Baraclude monotherapy with Baraclude plus tenofovir in treatment-naïve adult patients with HBeAg-positive and HBeAg-negative chronic hepatitis B with compensated liver disease.

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading